Steven Broll, Sumanta Basu, Myung Hee Lee, Martin T Wells
{"title":"PROLONG: penalized regression for outcome guided longitudinal omics analysis with network and group constraints.","authors":"Steven Broll, Sumanta Basu, Myung Hee Lee, Martin T Wells","doi":"10.1093/bioinformatics/btaf099","DOIUrl":null,"url":null,"abstract":"<p><strong>Motivation: </strong>There is a growing interest in longitudinal omics data paired with some longitudinal clinical outcome. Given a large set of continuous omics variables and some continuous clinical outcome, each measured for a few subjects at only a few time points, we seek to identify those variables that co-vary over time with the outcome. To motivate this problem we study a dataset with hundreds of urinary metabolites along with Tuberculosis mycobacterial load as our clinical outcome, with the objective of identifying potential biomarkers for disease progression. For such data clinicians usually apply simple linear mixed effects models which often lack power given the low number of replicates and time points. We propose a penalized regression approach on the first differences of the data that extends the lasso + Laplacian method [Li and Li (Network-constrained regularization and variable selection for analysis of genomic data. Bioinformatics 2008;24:1175-82.)] to a longitudinal group lasso + Laplacian approach. Our method, PROLONG, leverages the first differences of the data to increase power by pairing the consecutive time points. The Laplacian penalty incorporates the dependence structure of the variables, and the group lasso penalty induces sparsity while grouping together all contemporaneous and lag terms for each omic variable in the model.</p><p><strong>Results: </strong>With an automated selection of model hyper-parameters, PROLONG correctly selects target metabolites with high specificity and sensitivity across a wide range of scenarios. PROLONG selects a set of metabolites from the real data that includes interesting targets identified during EDA.</p><p><strong>Availability and implementation: </strong>An R package implementing described methods called \"prolong\" is available at https://github.com/stevebroll/prolong. Code snapshot available at 10.5281/zenodo.14804245.</p>","PeriodicalId":93899,"journal":{"name":"Bioinformatics (Oxford, England)","volume":" ","pages":""},"PeriodicalIF":5.4000,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11955234/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioinformatics (Oxford, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/bioinformatics/btaf099","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Motivation: There is a growing interest in longitudinal omics data paired with some longitudinal clinical outcome. Given a large set of continuous omics variables and some continuous clinical outcome, each measured for a few subjects at only a few time points, we seek to identify those variables that co-vary over time with the outcome. To motivate this problem we study a dataset with hundreds of urinary metabolites along with Tuberculosis mycobacterial load as our clinical outcome, with the objective of identifying potential biomarkers for disease progression. For such data clinicians usually apply simple linear mixed effects models which often lack power given the low number of replicates and time points. We propose a penalized regression approach on the first differences of the data that extends the lasso + Laplacian method [Li and Li (Network-constrained regularization and variable selection for analysis of genomic data. Bioinformatics 2008;24:1175-82.)] to a longitudinal group lasso + Laplacian approach. Our method, PROLONG, leverages the first differences of the data to increase power by pairing the consecutive time points. The Laplacian penalty incorporates the dependence structure of the variables, and the group lasso penalty induces sparsity while grouping together all contemporaneous and lag terms for each omic variable in the model.
Results: With an automated selection of model hyper-parameters, PROLONG correctly selects target metabolites with high specificity and sensitivity across a wide range of scenarios. PROLONG selects a set of metabolites from the real data that includes interesting targets identified during EDA.
Availability and implementation: An R package implementing described methods called "prolong" is available at https://github.com/stevebroll/prolong. Code snapshot available at 10.5281/zenodo.14804245.
动机:人们对与一些纵向临床结果相结合的纵向组学数据越来越感兴趣。给定大量连续组学变量和一些连续临床结果,每个变量仅在几个时间点对几个受试者进行测量,我们寻求识别那些随时间与结果共同变化的变量。为了激发这个问题,我们研究了一个包含数百种尿液代谢物以及结核分枝杆菌负荷的数据集作为我们的临床结果,目的是确定疾病进展的潜在生物标志物。对于这样的数据,临床医生通常采用简单的线性混合效应模型,由于重复次数和时间点少,这种模型往往缺乏效力。我们提出了一种惩罚回归方法,将lasso + Laplacian方法(Li and Li 2008)扩展为纵向组lasso + Laplacian方法。我们的方法,延长,利用数据的第一次差异,通过配对连续的时间点来增加功率。Laplacian惩罚结合了变量的依赖结构,而group lasso惩罚在将模型中每个经济变量的所有同期和滞后项组合在一起时引起稀疏性。结果:通过自动选择模型超参数,extend可以在各种情况下以高特异性和灵敏度正确选择目标代谢物。extend从真实数据中选择一组代谢物,包括EDA期间确定的有趣靶点。可用性:在https://github.com/stevebroll/prolong上有一个R包实现了所描述的名为“extend”的方法。代码快照可在10.5281/zenodo.14804245。结论:对于在高维纵向组学数据中选择与某些连续临床结果共变的潜在生物标志物,extend是一种强大的方法。